These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Three Finnish incontinentia pigmenti (IP) families with recombinations with the IP loci at Xq28 and Xp11. Hydén-Granskog C, Salonen R, von Koskull H. Hum Genet; 1993 Mar; 91(2):185-9. PubMed ID: 8096494 [Abstract] [Full Text] [Related]
12. Incontinentia pigmenti in male patients. Pacheco TR, Levy M, Collyer JC, de Parra NP, Parra CA, Garay M, Aprea G, Moreno S, Mancini AJ, Paller AS. J Am Acad Dermatol; 2006 Aug; 55(2):251-5. PubMed ID: 16844507 [Abstract] [Full Text] [Related]
13. Unstable pre-mutation may explain mosaic disease expression of incontinentia pigmenti in males. Traupe H, Vehring KH. Am J Med Genet; 1994 Feb 15; 49(4):397-8. PubMed ID: 8160732 [Abstract] [Full Text] [Related]
18. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, Chambon P, Rajewsky K, Krieg T, Haase I, Pasparakis M. Hum Mol Genet; 2006 Feb 15; 15(4):531-42. PubMed ID: 16399796 [Abstract] [Full Text] [Related]